Juvenescence, an anti-aging startup based in the British Isles, reeled in a $50 million series A, which will allow it to push forward on its "core projects" and ramp up licensing deals and partnerships. This fundraiser brings the company's total raised since its founding to $63 million.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,